New hope for tough colorectal cancer: drug cocktail targets BRAF mutation
Disease control
Not yet recruiting
This study tests a new combination of drugs (aipalolitovorelizumab, bevacizumab, and standard chemo) as a first treatment for people with advanced colorectal cancer that has a specific gene change called BRAF V600E. The goal is to see if this combo can shrink tumors and control t…
Phase: PHASE2 • Sponsor: Yanqiao Zhang • Aim: Disease control
Last updated May 26, 2026 11:02 UTC